Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Thiamazole

An antithyroid drug of the thionamide class, also known as methimazole, which reduces thyroid hormone production; in use since the late 1940s against hyperthyroidism, for example in Graves' disease. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?Antithyroid drugs were born in 1943, when endocrinologist Edwin Astwood published the first treatments of hyperthyroidism with thiourea and thiouracil; in 1949 Astwood himself studied methimazole.

ThiamazoleGo to the active ingredient →
ThiamazoleActive ingredientThiamazoleCat. No. P-T085-001CAS 60-56-0
Thiamazole-d3Isotopically labelledThiamazole-d3Cat. No. P-T085-008CAS 1160932-07-9

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Reference substanceThiamazole CRSEDQM code Y0000336Family Thiamazole

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.